| |
| |
|
| Insider
Information: |
Riley Anthony A |
| Relationship: |
|
| City: |
Fremont |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
197,274 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$691,553 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
197,274 |
|
|
| Total
Value |
$691,553 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Krystal Biotech Inc |
KRYS |
Chief Financial Officer |
2018-05-22 |
2,800 |
2018-05-22 |
0 |
Premium* |
|
|
Forte Biosciences Inc |
FBRX |
|
2024-04-01 |
194,474 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
14 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| FBRX |
Forte Biosciences Inc |
CHIEF FINANCIAL OFFICER |
• – – |
2024-04-01 |
4 |
D |
$0.71 |
$2,367 |
D/D |
(3,345) |
194,474 |
0 |
- |
|
| FBRX |
Forte Biosciences Inc |
CHIEF FINANCIAL OFFICER |
• – – |
2024-04-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,375 |
197,819 |
0 |
- |
|
| FBRX |
Forte Biosciences Inc |
Chief Financial Officer |
• – – |
2024-01-01 |
4 |
D |
$0.82 |
$3,156 |
D/D |
(3,841) |
188,444 |
0 |
- |
|
| FBRX |
Forte Biosciences Inc |
Chief Financial Officer |
• – – |
2024-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,375 |
192,285 |
0 |
- |
|
| FBRX |
Forte Biosciences Inc |
Chief Financial Officer |
• – – |
2023-10-01 |
4 |
D |
$0.66 |
$2,146 |
D/D |
(3,241) |
182,910 |
0 |
- |
|
| FBRX |
Forte Biosciences Inc |
Chief Financial Officer |
• – – |
2023-10-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,375 |
186,151 |
0 |
- |
|
| FBRX |
Forte Biosciences Inc |
Chief Financial Officer |
• – – |
2023-07-31 |
4 |
A |
$1.01 |
$149,999 |
D/D |
148,514 |
176,776 |
0 |
- |
|
| FBRX |
Forte Biosciences Inc |
Chief Financial Officer |
• – – |
2023-07-01 |
4 |
D |
$1.04 |
$3,371 |
D/D |
(3,241) |
24,762 |
0 |
- |
|
| FBRX |
Forte Biosciences Inc |
Chief Financial Officer |
• – – |
2023-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,375 |
28,003 |
0 |
- |
|
| FBRX |
Forte Biosciences Inc |
Chief Financial Officer |
• – – |
2021-09-07 |
4 |
S |
$4.24 |
$106,105 |
D/D |
(25,000) |
11,065 |
0 |
% |
|
| FBRX |
Forte Biosciences Inc |
Chief Financial Officer |
• – – |
2020-06-29 |
4 |
B |
$14.11 |
$28,220 |
D/D |
2,000 |
36,065 |
2.74 |
- |
|
| FBRX |
Forte Biosciences Inc |
Chief Financial Officer |
• – – |
2020-06-26 |
4 |
B |
$14.52 |
$68,225 |
D/D |
4,700 |
34,065 |
2.74 |
- |
|
| FBRX |
Forte Biosciences Inc |
Chief Financial OfficerOfficer |
• – – |
2020-06-15 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
29,365 |
|
- |
|
| KRYS |
Krystal Biotech Inc |
Chief Financial Officer |
• – – |
2018-05-22 |
4 |
B |
$10.75 |
$30,100 |
D/D |
2,800 |
2,800 |
2.74 |
- |
|
14 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
